[HTML][HTML] The prognostic value of tumor-infiltrating lymphocytes in head and neck squamous cell carcinoma: A systematic review and meta-analysis
M Torri, A Sandell, A Al-Samadi - Biomedicine & Pharmacotherapy, 2024 - Elsevier
Head and neck squamous cell carcinoma (HNSCC) is experiencing a rising incidence and
mortality worldwide, emphasizing the need for reliable prognostic markers. Tumor-infiltrating …
mortality worldwide, emphasizing the need for reliable prognostic markers. Tumor-infiltrating …
Therapeutic potential of antibody-drug conjugate-based therapy in head and neck cancer: a systematic review
Simple Summary Head and neck cancer (HNC) is a complex and extremely heterogeneous
disease that includes a wide variety of cancer subtypes. Despite notable advances in …
disease that includes a wide variety of cancer subtypes. Despite notable advances in …
[PDF][PDF] Defining the role of B7-H3 (CD276) in epithelial homeostasis and cancer progression
Abstract B7-H3 (CD276) is a member of the B7 superfamily and shares up to 30% amino
acid identity with other B7 family members. It is expressed in a wide range of cell types and …
acid identity with other B7 family members. It is expressed in a wide range of cell types and …
[HTML][HTML] Towards more reliable in vitro drug testing for head and neck squamous cell carcinoma via a human tumor–derived matrix
K Tuomainen - 2021 - helda.helsinki.fi
Head and neck cancer (HNSCC) is the 8th most common cancer globally. Despite improved
therapy, the 5-year survival rate has remained stagnant, at approximately 50%. Current …
therapy, the 5-year survival rate has remained stagnant, at approximately 50%. Current …